Cargando…

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials

BACKGROUND: The therapeutic role of neuromuscular blocking agents (NMBA) in patients with acute respiratory distress syndrome (ARDS) remains controversial. METHODS: We systematically reviewed randomized controlled trials investigating the use of NMBA in ARDS patients from inception to July 2019. Rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xue-biao, Wang, Zhong-hua, Liao, Xiao-long, Guo, Wei-xin, Qin, Tie-he, Wang, Shou-hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000374/ https://www.ncbi.nlm.nih.gov/pubmed/32063852 http://dx.doi.org/10.3389/fphar.2019.01637

Ejemplares similares

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
por: Zheng, Zhongjun, et al.
Publicado: (2020)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
por: Tarazan, Nehal, et al.
Publicado: (2020)

Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
por: Chang, Wei, et al.
Publicado: (2020)

Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
por: Torbic, Heather, et al.
Publicado: (2019)

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
por: Courcelle, Romain, et al.
Publicado: (2020)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey
por: Kim, Jin Sun, et al.
Publicado: (2019)

Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
por: Chiang, Chih-Chao, et al.
Publicado: (2020)

Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Alhazzani, Waleed, et al.
Publicado: (2013)

The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients
por: Hadique, Sarah, et al.
Publicado: (2021)

Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression
por: Shao, Shuai, et al.
Publicado: (2020)

Alleviation of Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats by Yiqi Huayu Jiedu Decoction: A Tandem Mass Tag-Based Proteomics Study
por: Luo, Chang-yong, et al.
Publicado: (2020)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Pereira, VGM
Publicado: (2013)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Neto, Ary Serpa, et al.
Publicado: (2012)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation
por: Pan, Li-Long, et al.
Publicado: (2017)

Phospholipid-mimicking block, graft, and block-graft copolymers for phase-transition microbubbles as ultrasound contrast agents
por: Huang, Jianbo, et al.
Publicado: (2022)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis
por: Hua, Yusi, et al.
Publicado: (2020)

The protective effects of baicalin for respiratory diseases: an update and future perspectives
por: Song, Siyu, et al.
Publicado: (2023)

An update on the development of novel antifungal agents for eumycetoma
por: Chandler, David J., et al.
Publicado: (2023)

Andrographolide, a natural anti-inflammatory agent: An Update
por: Li, Xiaohong, et al.
Publicado: (2022)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

Network analysis-based strategy to investigate the protective effect of cepharanthine on rat acute respiratory distress syndrome
por: Chen, Chen, et al.
Publicado: (2022)

The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study
por: Yang, Jia-Wei, et al.
Publicado: (2021)

Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis
por: Wang, Liu, et al.
Publicado: (2023)

Editorial: The Potential Effect and Mechanism of Traditional Medicine on Vascular Homeostasis and Remodeling: An Update
por: Zhang, Yuefan, et al.
Publicado: (2022)

Comparative Effectiveness of Midazolam, Propofol, and Dexmedetomidine in Patients With or at Risk for Acute Respiratory Distress Syndrome: A Propensity Score-Matched Cohort Study
por: Hu, An-Min, et al.
Publicado: (2021)

An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer
por: Rajkovic, Jovana, et al.
Publicado: (2023)

Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway
por: Tung, Yu-Tang, et al.
Publicado: (2022)

Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy
por: Fujinaga, Jun, et al.
Publicado: (2019)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

STC3141 improves acute lung injury through neutralizing circulating histone in rat with experimentally-induced acute respiratory distress syndrome
por: Ge, Yangyang, et al.
Publicado: (2023)

Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway
por: Zhang, Pan, et al.
Publicado: (2021)

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome
por: Bricher Choque, Pamela Nithzi, et al.
Publicado: (2021)

Update in acute respiratory distress syndrome
por: Koh, Younsuck
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bm69e8mfo9o15g6cmg8ol1mrsn